Recent Advancement in Drug Targeting Therapies in the Treatment of Pancreatic Cancer
This review concludes that although improvement in therapies for PDAC has incrementally been proven in recent literature, however, more research is expected to enhance these approaches so that they can be applied appropriately at the clinical stage. In future studies, it is expected to optimize treatment combinations, address mechanisms of resistance, and improve the delivery of drugs.
Authors
- Amin Gasmi (ORCID: https://orcid.org/0000-0003-2165-8373)
- Ranjit K. Harwansh (ORCID: https://orcid.org/0000-0002-9192-5265)
- Rohitas Deshmukh (ORCID: https://orcid.org/0000-0002-8962-6821)
- Pratap Kumar Patra (ORCID: https://orcid.org/0000-0002-0338-7517)
- Junainah Abd Hamid (ORCID: https://orcid.org/0000-0003-3078-6123)
- Pranay Wal
Institutions
- Management and Science University (MY)
- Chandra Shekhar Azad University of Agriculture and Technology (IN)
- Société Francophone d’Arthroscopie (FR)
- Centurion University of Technology and Management (IN)
- GLA University (IN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-02-28
- DOI
- https://doi.org/10.2174/0113816128334659241223113743
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05